Navigation Links
9/11 Firefighters' Can Regain Lung Capacity: Study

A new study appearing in the American Journal of Respiratory and Critical Care Medicine says that firefighters //at Ground Zero on September 11 had a loss in lung capacity equivalent to what usually happens after 12 years on duty a year after the terror attacks.

An average loss of 372 milliliters was noted, which is equal to 6 percent of the lung's capacity. This loss is at least 10 times more than the annual age-related loss in ordinary persons. But doctors said that with proper monitoring and care, the lung capacities of such 9/11 firefighters could return to normal.

Dr. David J. Prezant, co-director of the Fire Department's World Trade Center Medical Monitoring Program, and an author of the study, said that the lungs would cure and clean themselves up naturally and restore the proper capacity to breathe.

However Stephen J. Cassidy, president of the Uniformed Firefighters Association said that most firefighters were aware of having health problems. "It's not just that firefighters lost 12 years in the blink of an eye," he said. "We're approaching the fifth anniversary, and most firefighters working today wonder where they will be in five years, healthwise."

Dr. Prezant maintains that the dust particles may be exhaled or dissolve over time. Firefighters have till now been given steroids and nasal and pulmonary decongestants. "Anecdotally, I can say that people in the treatment program, especially those who have had early diagnosis and treatment, feel that their lung function is plateauing or improving," he said. "We have not seen further decreases."
'"/>




Page: 1

Related medicine news :

1. Possibility Of Regaining Speech After Tongue, Voice Box Removal
2. Sharon Unlikely To Regain Consciousness
3. Will Teflon Regain Its Rightful Place In The Kitchen?
4. Hearing May Be Regained: Research Provides Hopes
5. Muscles May Need Estrogen to Regain Strength, Especially as Women Age
6. King/Drew Medical Center Determined To Regain Past Glory
7. MMR Vaccines on Its Way to Regain Past Glory
8. Cuban Deaf-blind Children Regain Hearing
9. Tomato Sauce reduces Cancer Risk- Study
10. Study on obesity and heart failure
11. National Lung Study in the process
Post Your Comments:
(Date:12/2/2008)...ed with radiation prior to surgery for advanced re...nce and better overall survival rates, according t...ed a treatment called neoadjuvant therapy, which c... of cancer, before surgery to remove the tumor. Ne...radiation. , Neoadjuvant therapy should not be ...
(Date:12/2/2008)...n the December 1, 2008, issue of Clinical Cancer ...or Cancer Research, show lapatinib benefits women ... HER2-negative breast cancer or those who express ...ion, a misclassification of metastatic breast canc... people from receiving optimal therapy. , Lapat...
(Date:12/2/2008)...FirstCall/ - NUCRYST Pharmaceuticals Corp., a deve...ght infection and inflammation, announced today th...jority shareholder, The Westaim Corporation ("West...shareholders to consider a return of capital of US...tes to a return of capital of approximately US$15 ...
(Date:12/2/2008)...Call/ -- Today Pascal Metrics Inc.,publicly annou...sk management,services for hospitals and healthca...etrics rapidly has become a worldwide leader for c...d other regulatory requirements, to reduce,costs,...e patients safer from,medical failure and errors....
Breaking Medicine News(10 mins):Health News:HER2 levels may aid in treatment selection for metastatic breast cancer 2Health News:NUCRYST Receives Requisition to Call a Special Meeting of Shareholders From Majority Shareholder 2Health News:NUCRYST Receives Requisition to Call a Special Meeting of Shareholders From Majority Shareholder 3Health News:Pascal Metrics Announces Patient Safety Culture Services Offering 2
... heart becomes so enlarged that it is no longer ab...s 35 in every 100,000 people. Researchers in the U...ished in the journal Science that a defect in the ...ays a key role in regulating the flow of calcium t...
...f The Anatomical Record has put together a collect...ry repair in animals. Spinal cord injury affects m...th little hope of living a normal life. However, r...tem cells - primitive cells that can turn into spe...
...ases in our society with more than five million pe...one. According to a major study in the UK, in whic...st 900,000 asthma patients across the UK, asthma s...t being prescribed the most suitable inhalers. The...
...at can often be fatal. Methadone has been one of t... However, the major concern in treating heroin add...ddictive. This is one reason methadone therapy is ...tudy has now found that an alternative drug therap...
Other Medicine News:
(Date:11/26/2008)...e-USNewswire/ -- Children whose eyes are misaligne... risk of developing mental illness by early adulth... published this month in Pediatrics , the official... , The retrospective study examined the medi...igned eyes) and compared them with records of chil...
(Date:11/26/2008)... , FRANKLIN, Mass., Nov. 26 /PRNewswire-FirstCa...) announced today that it has received full approv...) for its U.S. pivotal trial to study the effectiv...associated therapy in the prevention of Contrast-I...approved PLC,s request to expand their investigati...
(Date:11/25/2008)...-USNewswire/ -- Kleinert Kutz and University of L...hand transplant on Messina, New York resident, Jan...Hand Care Center on Monday, November 24. The inno...ed shortly after 9 p.m. in a record nine hours. ,...prnh/20081125/DC48555-a ) , (Photo: http://ww...
(Date:11/25/2008)... Proteolix, Inc., a,leader in the...hat target,protein degradation pathways in cancer...ta from two ongoing Phase 2 clinical trials of car... the upcoming 50th Annual Meeting of the,American...first in a new class,of specific proteasome inhib...
Breaking Medicine Technology:Eye Divergence in Children Triples Risk of Mental Illness 2PLC Systems Receives Full FDA Approval for Pivotal Study of RenalGuard(TM) in The U.S. 2PLC Systems Receives Full FDA Approval for Pivotal Study of RenalGuard(TM) in The U.S. 3PLC Systems Receives Full FDA Approval for Pivotal Study of RenalGuard(TM) in The U.S. 4Kleinert Kutz Hand Surgeons Perform Fifth U.S. Hand Transplant in Record Time at Jewish Hospital Hand Care Center 2Kleinert Kutz Hand Surgeons Perform Fifth U.S. Hand Transplant in Record Time at Jewish Hospital Hand Care Center 3Proteolix to Present Clinical and Preclinical Data at the 50th Annual Meeting of the American Society of Hematology 2Proteolix to Present Clinical and Preclinical Data at the 50th Annual Meeting of the American Society of Hematology 3BioMarin Re Acquires Rights to Kuvan in Canada From Merck Serono 8454 1BioMarin Re Acquires Rights to Kuvan in Canada From Merck Serono 8454 2BioMarin Re Acquires Rights to Kuvan in Canada From Merck Serono 8454 3BioMarin Re Acquires Rights to Kuvan in Canada From Merck Serono 8454 4Dr Peter B Corr Joins Team at Celtic Therapeutics as General Partner 8450 1Dr Peter B Corr Joins Team at Celtic Therapeutics as General Partner 8450 2Dr Peter B Corr Joins Team at Celtic Therapeutics as General Partner 8450 3Dr Peter B Corr Joins Team at Celtic Therapeutics as General Partner 8450 4Laser Therapy Gives Smokers Hope for Successful New Years Resolution 2265 1Laser Therapy Gives Smokers Hope for Successful New Years Resolution 2265 2WellGen Inc Names Nancy E Rawson Ph D Chief Scientific Officer 2261 1WellGen Inc Names Nancy E Rawson Ph D Chief Scientific Officer 2261 2WellGen Inc Names Nancy E Rawson Ph D Chief Scientific Officer 2261 3
... SEATTLE, June 04, 2007 /PRNewswire-FirstCall/ --...indings were presented from a,Phase 1b clinical tr...eukemia (B-CLL) at the American Society of Clinica...ncluded intravenous,administration of higher doses...ound that atacicept was well-tolerated and biologi...
... HAWTHORNE, N.Y.--(BUSINESS WIRE)--Jun 4, 2007 - A...nnounced that the,Company presented a "meta-analys... Fampridine-SR in multiple sclerosis during a,post... and Research,in MS (ACTRIMS) Meeting in Washingto...lidation of Consistent Improvement in Walking,Spee...
Other Medicine Technology:ZymoGenetics Reports Results From Atacicept Phase 1b Clinical Trial,in B-Cell Chronic Lymphocytic Leukemia 2ZymoGenetics Reports Results From Atacicept Phase 1b Clinical Trial,in B-Cell Chronic Lymphocytic Leukemia 3Acorda Therapeutics Presents Fampridine-SR Data at ACTRIMS Meeting 2Acorda Therapeutics Presents Fampridine-SR Data at ACTRIMS Meeting 3Acorda Therapeutics Presents Fampridine-SR Data at ACTRIMS Meeting 4
...e Acuity LT Central Monitoring Station allows emer... Delivery Area when and where it's needed. Central...-site in response to emergency situations to incre...nvolved., ,Used in conjunction with Welch Allyn's...
...ble and easy-to-use 3800 and 3900/P pulse oximeter...gy, the proprietary clinical patient motion algori...proved performance:, ,The 3800 and 3900 pulse.../ mechanical stress testing such as rough handling...
... the power of clinical information. , ,S/5 Clinic...ical connectivity solutions that help you and your...ent care. You will have access to essential patien...re team and specialists, independent of time and l...
...monitoring for intermediate care., ,The S/5 FM is...da S/5 product line., ,The S/5 FM has a modular d...tient Side Module (PSM) includes a comprehensive p...ECG, NIBP, motion-tolerant SpO 2 , 2 temperatures ...
Medicine Products: